Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Andoniou

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Blood|May 16, 2013
CpG pretreatment enhances antiviral T-cell immunity against cytomegalovirusMonique L Ong, Matthew E Wikstrom, Peter Fleming, et al.
Cell Reports|March 29, 2018
The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1sSam Sheppard, Iona S Schuster, Christopher E Andoniou, et al.
European Journal of Immunology|October 30, 2013
The early monocytic response to cytomegalovirus infection is MyD88 dependent but occurs independently of common inflammatory cytokine signalsMatthew E Wikstrom, Andrea Khong, Peter Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
NK cells require IL-28R for optimal in vivo activityFernando Souza-Fonseca-Guimaraes, Arabella Young, Deepak Mittal, et al.
Scientific Reports|October 29, 2017
Ocular antigen does not cause disease unless presented in the context of inflammationValentina Voigt, Matthew E Wikstrom, Jelena M Kezic, et al.
Science (New York, N.Y.)|January 19, 2019
Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantationJose Paulo Martins, Christopher E Andoniou, Peter Fleming, et al.
Nature Immunology|September 6, 2005
Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunityChristopher E Andoniou, Serani L H van Dommelen, Valentina Voigt, et al.
Cell Reports|June 12, 2024
DOT1L maintains NK cell phenotype and function for optimal tumor controlHarrison Sudholz, Iona S Schuster, Momeneh Foroutan, et al.
Journal of Virology|May 31, 2022
Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression <i>In Vitro</i> and Prevents Lesion Formation in the Mouse Zosteriform ModelMelkamu B Tessema, Rubaiyea Farrukee, Christopher E Andoniou, et al.
Blood|July 2, 2015
Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in miceMatthew E Wikstrom, Peter Fleming, Rachel D Kuns, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Blood|May 16, 2013
CpG pretreatment enhances antiviral T-cell immunity against cytomegalovirusMonique L Ong, Matthew E Wikstrom, Peter Fleming, et al.
Cell Reports|March 29, 2018
The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1sSam Sheppard, Iona S Schuster, Christopher E Andoniou, et al.
European Journal of Immunology|October 30, 2013
The early monocytic response to cytomegalovirus infection is MyD88 dependent but occurs independently of common inflammatory cytokine signalsMatthew E Wikstrom, Andrea Khong, Peter Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
NK cells require IL-28R for optimal in vivo activityFernando Souza-Fonseca-Guimaraes, Arabella Young, Deepak Mittal, et al.
Scientific Reports|October 29, 2017
Ocular antigen does not cause disease unless presented in the context of inflammationValentina Voigt, Matthew E Wikstrom, Jelena M Kezic, et al.
Science (New York, N.Y.)|January 19, 2019
Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantationJose Paulo Martins, Christopher E Andoniou, Peter Fleming, et al.
Nature Immunology|September 6, 2005
Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunityChristopher E Andoniou, Serani L H van Dommelen, Valentina Voigt, et al.
Cell Reports|June 12, 2024
DOT1L maintains NK cell phenotype and function for optimal tumor controlHarrison Sudholz, Iona S Schuster, Momeneh Foroutan, et al.
Journal of Virology|May 31, 2022
Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression <i>In Vitro</i> and Prevents Lesion Formation in the Mouse Zosteriform ModelMelkamu B Tessema, Rubaiyea Farrukee, Christopher E Andoniou, et al.
Blood|July 2, 2015
Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in miceMatthew E Wikstrom, Peter Fleming, Rachel D Kuns, et al.
Pageof 5